grants_govPA-27-101
Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Department of Health and Human Services
- Response deadline
- Apr 5, 2029 Due in 1008 days
- Date posted
- May 28, 2026
- Source
- Open notice
Description
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
Classifications
- NAICS93.853
Documents (1)
- DownloadPA-27-101-Revised-Full-Announcement.htmltext/html;charset=UTF-8170 KB
Contacts
- National Institutes of Healthseedinfo@nih.gov301-402-2541